What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives 
Sensei Biotherapeutics Reports First Quarter 2021 Results and Provides Business Update
- ImmunoPhage™ platform programs and the VISTA program continue to advance - - New safety and efficacy data from ongoing...
Verrica Pharmaceuticals Announces Participation in the 2021 RBC Capital Markets Global Healthcare Conference
WEST CHESTER, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing...
AzurRx BioPharma Receives Approximately $550K for its 2020 CIR (French Research Tax Credit)
DELRAY BEACH, Fla., May 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical...
Cassava Sciences Announces New $2.7 Million Research Grant Award from National Institutes of Health
- Research Grant Will Support Clinical Readiness Activities in Support of Upcoming Phase 3 Program with Simufilam -AUSTIN, Texas, May...
Minerva Neurosciences Reports First Quarter 2021 Financial Results and Business Updates
Top-line results from the open-label extension of phase 3 monotherapy trial of roluperidone for the treatment of negative symptoms of...
Aptose to Present at Upcoming Investor Conferences
SAN DIEGO and TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company...
Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with Vectorized Anti-Tau Antibody
Findings to be presented at the 24th Annual Meeting of the American Society of Gene and Cell Therapy Data demonstrate...
Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate Update
~ Reports KEVEYIS® (dichlorphenamide) First Quarter 2021 Revenue of $8.4 Million, a 25 Percent Increase Compared to $6.7 Million of Revenue During First Quarter...
Adamis Pharmaceuticals Schedules First Quarter 2021 Financial Results Conference Call and Business Update
SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty...
InflaRx Reports First Quarter 2021 Financial & Operating Results
Severe COVID-19 trial enrollment reaches 178 patients; interim analysis expected in Q3At the FDA’s suggestion, planning to request a Type...
Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data
TMS-007 has the potential to be a next generation thrombolytic with an improved benefit-risk profile Acute ischemic stroke is caused...
Graybug Vision Announces First Quarter 2021 Financial Results and Recent Corporate Developments
REDWOOD CITY, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on...
VitalHub Subsidiary Wins Technology Company of the Year Award
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that...
Ocuphire Completes Enrollment in VEGA-1 Phase 2 Clinical Trial Investigating Nyxol® in Combination with Low-Dose Pilocarpine for Treatment of Presbyopia
Nyxol has Potential to be a New Eye Drop Treatment Option for Presbyopia Top-Line VEGA-1 Data Expected by End of Q2 2021 FARMINGTON HILLS, Mich., May 12, 2021 (GLOBE...
Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
Studies show location accuracy and tolerability of the novel oral Drug Delivery System (DDS) and point to a materially enhanced...
Algernon Pharmaceuticals Announces Ifenprodil Reduced Interleukin 6 in Phase 2b/3 COVID Study
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or...
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board Brings decades of leadership experience in the Global MedTech sector...
LevelJump Closes $1.5 Million Non-Brokered Private Placement with Strategic Investors
Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...
Inogen Announces Participation in the 41st Annual William Blair Virtual Growth Stock Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Global Enteral Feeding Devices Market to Surpass US$ 4,853.8 Million by 2027, Says Coherent Market Insights (CMI)
SEATTLE--(BUSINESS WIRE)--#EnteralFeeding--According to Coherent Market Insights, the global enteral feeding devices market is estimated to be valued at US$ 3,260.6...